Knight Therapeutics | GUD - Marktkapitalisierung

Aktienkurs
7.55
Täglich Wechseln
-0.10 -1.31%
Monatlich
21.97%
Jährlich
35.06%
Q2 Prognose
7.37




Marktkapitalisierung Veränderung Datum
Akebia Therapeutics USD 427M 297M 2025-12
Alaunos Therapeutics USD 5M 5M 2025-09
Aurora Cannabis CAD 327.21M 142.93M 2025-12
Avita Medical AUD 105.47M 35.32M 2025-12
Canopy Growth CAD 656.46M 124.89M 2025-12
Cronos Group USD 1B 55.93M 2025-12
Dianthus Therapeutics USD 1.78B 215M 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
IQVIA Holdings USD 38.39B 6.1B 2025-12
Knight Therapeutics CAD 600.53M 14.56M 2025-12
Organigram Holdings CAD 312.16M 66.64M 2025-12
Organon & Co USD 1.86B 916.43M 2025-12
Revvity USD 10.97B 1.21B 2025-12
Tectonic Therapeutic USD 390M 96M 2025-12
Viatris USD 14.34B 2.8B 2025-12
Xeris Pharmaceuticals USD 1.3B 12M 2025-12